News Archives - Page 379 of 735

MondaySep 20, 2021 12:35 pm

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Lining Things Up for a Successful Rest of the Year, 2021

PlantX has made important moves recently, including additions to its Board of Directors, and the decision to commence an NCIB to repurchase up to 5% of its common shares Going forward, the company plans to sustain its ongoing retail branding initiative-renaming existing brick-and-mortar stores as “XMarket” Physical stores in British Columbia, Squamish, and Venice Beach, California, will be re-branded as XMarket The XMarket Squamish store will host a grand opening event on October 14, 2021, while the Tel Aviv one is scheduled for opening on November 15, 2021 PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) recently marked some significant…

MondaySep 20, 2021 12:04 pm

Moon Equity Holdings Corp. (MONI) Reveals Attendance at 2021 SALT Conference

MONI is an investment company focusing on acquisitions in the fintech, crypto, precious metals, and real estate sectors MONI reveals its participation in the annual SALT Conference, one of the world's premier hedge fund events held in New York between September 13-15, 2021 In addition to their marketing efforts, MONI is actively expanding their business – including the acquisition of mining company, Royal Costino LLC, and the development of their cryptocurrency business Moon Equity Holdings (OTC: MONI) is an investment company focusing on acquisitions in fintech, crypto, precious metals, and real estate sectors. The company has centered its business philosophy around…

MondaySep 20, 2021 11:51 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Shares Progress Update, Corporate Presentation, with Investors at H.C. Wainwright Conference

The company has completed many milestones to date, with plans to finalize its Phase 2 Hydrogen-Ammonia Synthesizer commercial prototype by the end of 2021, and other high-visibility projects planned for 2022 Hydrogen transportation and storage poses a problem on account of volatility and high costs, but carbon-free ammonia is a cost-efficient and environmentally logical alternative The weather of 2021 has been a key indicator of the climate changes that are taking place and the need to work toward the net-zero 2050 plans made globally FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a growth-stage company focused on providing commercially viable and sustainable clean…

MondaySep 20, 2021 11:38 am

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) POC Lab Test Ecosystem Rollout Advances Fight Against COVID, Flu, RSV, Chronic Conditions

Health diagnostics technology innovator Avricore Health has introduced its HealthTab platform as a means of improving patients’ ability to monitor their health conditions through point-of-care testing under the guidance of trained pharmacists HealthTab uses partnerships with molecular testing device makers to establish rapid molecular testing services in pharmacies, including the Shoppers Drug Mart pharmacy network in Ontario The initial rollout has taken place in 15 Shoppers pharmacies, with rapid scaling planned to achieve more than 600 locations by the end of 2023 HealthTab’s diagnostics platform is designed to be high quality with appropriate approvals and certifications, helping patients to avoid…

MondaySep 20, 2021 10:45 am

Technology Pioneer Dozy Mmobuosi Intends to Transform a Continent with Tingo Inc. (IWBB)

Dozy Mmobuosi, CEO and co-founder of Tingo Mobile, aims to accelerate digital commerce in Agritech and Fintech verticals across Africa Mmobuosi spearheaded the design and launch of Nigeria’s first SMS banking solution and has led Tingo’s growth to more than $600 million in annual revenue Tingo’s innovative mobile Agritech and Fintech platforms and credit solutions bolster commerce, connect markets and provide mobile banking services Due to growing need and demand, Mmobuosi expects Tingo Mobile to become the continent’s leading Agri-Fintech business powered through smartphone technology Dozy Mmobuosi founded Tingo Mobile in 2001 to bring mobile technology and Fintech solutions to…

MondaySep 20, 2021 10:38 am

Sugarmade Inc. (SGMD) Ideally Positioned in Billion-Dollar Space ‘Ripe for Cannabis Delivery’

States that have already legalized cannabis are seeing a spike in business thanks to the overwhelming convenience of cannabis delivery Article reports that delivery services can “help surge revenue for retailers that jump in to take advantage” Earlier this year, SGMD launched a new business initiative for the licensed delivery of cannabis products According to a recent article, states that have already legalized cannabis, such as California, are seeing a spike in business thanks to the overwhelming convenience of cannabis delivery (https://ibn.fm/AGyL4). This is great news for Sugarmade (OTC: SGMD), an innovator in the dynamic California cannabis scene with majority…

FridaySep 17, 2021 9:15 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Phase Two Growth Plans, CEO Interview on Gamechangers LIVE

FuelPositive announced four new appointments – Nelson Leite and Olushola Ashiru have joined the Board, while Francois Desloges and Jennifer Spencer have been appointed to the Executive Leadership Team The appointments are in a move to actualize Phase Two of the company’s Hydrogen-Ammonia Synthesizer commercial prototype system, critical to its future growth FuelPositive’s CEO expressed enthusiasm with the new appointments, citing that they will be integral to the company’s plans for creating and developing technologies and solutions to fight climate change The company’s CEO also appeared on the Gamechangers LIVE podcast, where he shared his personal story, background, mindset, struggles…

FridaySep 17, 2021 9:15 am

Nemaura Medical Inc. (NASDAQ: NMRD) Is ‘One to Watch’

Nemaura’s flagship product, sugarBEAT(R), is a wearable, non-invasive and flexible Continuous Glucose Monitor (“CGM”) designed for people with diabetes and prediabetes sugarBEAT received CE mark clearance in May 2019, allowing it to be marketed and sold within the European Union, and Nemaura has submitted a premarket approval application to the U.S. FDA Nemaura continues to build a world-class management team Nemaura plans to launch a direct to consumer metabolic health program in 2021, using its glucose monitoring platform at the core of the program Nemaura has several patents (both filed and pending) and substantial trade secrets covering its technology platform…

FridaySep 17, 2021 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Signs Definitive Agreement to Acquire 100% of BayMedica Inc., Positioning it to Stand Distinct in Rare Cannabinoids Manufacturing, Become a Revenue-Generating Company, Expand Drug Development Capabilities

InMed Pharmaceuticals recently announced it has entered a definitive agreement to acquire 100% of BayMedica Inc. BayMedica is a private company that specializes in the manufacture and commercialization of rare cannabinoids Upon closing, the transaction will make InMed a global leader in the manufacturing of rare cannabinoids in addition to transforming it into a revenue-generating company Acquisition provides InMed with the complete flexibility across multiple manufacturing approaches On September 13, InMed Pharmaceuticals (NASDAQ: INM), a company developing cannabinoid-based pharmaceutical drug candidates and manufacturing technologies for pharmaceutical-grade rare cannabinoids, announced it has signed a definitive agreement to acquire 100% of BayMedica…

FridaySep 17, 2021 9:00 am

Differentiated Approach in Psychedelics Boosts Confidence in Upcoming Clinical Trials for Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF)

Pharmaceutical company Tryp Therapeutics is pursuing novel solutions to medical conditions with unmet needs, working to establish the efficacy and safety of the company’s trademarked synthetic psychedelic drug candidate The company’s products — TRP-8802 and TRP-8803 — aim to provide new therapies for select eating disorders with specific neurological causes, as well as pain and addition concerns Tryp is preparing Phase 2a and Phase 2b clinical trials and expects to advance its Psilocybin-for-Neuropsychiatric Disorders (“PFN”) platform in conjunction with research teams at the University of Florida and the University of Michigan The DEA recently recommended a significant increase in cannabis…

Site Search

Company Search

Category: News